Case histories - Dexela
Dexela was founded in 2005 to commercialise methods of tomosynthesis for breast cancer screening and other low-dose medical x-ray imaging applications. The company built a portfolio of intellectual property in this field and is a leader in the core imaging geometry IPR, computational techniques for image reconstruction and viewing workstations for tomosynthesis.
In 2008, Dexela acquired Aviex LLC, and developed a family of novel large-area CMOS X-ray detectors.
|
|
| 2923 CMOS X-ray detector (packaged)
|
Dexela Flat Panel CMOS X-ray Detector (unpackaged)
|
The Dexela detectors are ideal for breast tomosynthesis and mammography, and are a major advance on existing products for fluoroscopy, dental CT, and non-destructive testing (NDT).
Robert joined as a Non-Executive Director in 2010 to help the company grow its semiconductor business.
Dexela was sold in 2011 to Perkin Elmer.